Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The study investigators are testing to see if patients receiving radiation treatment for brain cancer along with raloxifene plus memantidine take longer to develop memory issues. The study will include anyone over the age of 18 who will be treated with radiation for brain cancer.
Epistemonikos ID: 69863a51e1bd2a903154102142070c0b30ea822e
First added on: Mar 14, 2026